(Total Views: 289)
Posted On: 03/02/2022 8:54:53 AM
Post# of 109
7 THINGS TO KNOW ABOUT AMICUS THERAPEUTICS
$FOLD
Amicus Therapeutics, Inc. (NASDAQ: FOLD), a biotechnology company developing cutting-edge therapeutics for treatment of rare metabolic diseases, announced that the proposed Business Combination Agreement with ARYA Sciences Acquisition Corp IV, a special purpose acquisition company has been mutually terminated owing to unfavorable market conditions currently prevailing.
Read on to find out more!
https://www.aviseanalytics.com/7-things-to-kn...rapeutics/
$FOLD
Amicus Therapeutics, Inc. (NASDAQ: FOLD), a biotechnology company developing cutting-edge therapeutics for treatment of rare metabolic diseases, announced that the proposed Business Combination Agreement with ARYA Sciences Acquisition Corp IV, a special purpose acquisition company has been mutually terminated owing to unfavorable market conditions currently prevailing.
Read on to find out more!
https://www.aviseanalytics.com/7-things-to-kn...rapeutics/
(0)
(0)Scroll down for more posts ▼
